13F Data
13F filer · CIK 1910456

Lynx1 Capital Management LP

DORADO, PR · filing since Q4 2021 · last filing Aug 13, 2026
Reported value
$865.5M
+$232.8M vs prior
Positions
27
New / sold out
6 / 2
Added / reduced
6 / 7
Turnover
11.2%
buys $102.6M · sells $84.0M
Top-10 weight
98.8%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedGH RESEARCH PLC+2,500,000+23.2%+$67.2M
AddedAGIOS PHARMACEUTICALS INC+797,369+30.5%+$29.6M
NewPLIANT THERAPEUTICS INC+1,798,070–+$2.0M
AddedC4 THERAPEUTICS INC+327,789+4.7%+$1.5M
AddedPROQR THRAPEUTICS N V+452,927+661.3%+$842.4K
AddedTRAWS PHARMA INC+544,392+3610.5%+$459.1K
NewFOGHORN THERAPEUTICS INC+61,588–+$300.5K
AddedPASSAGE BIO INC+50,055+8.0%+$244.3K
NewAVALO THERAPEUTICS INC+10,100–+$186.6K
NewNUVATION BIO INC+16,029–+$91.0K
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedDENALI THERAPEUTICS INC-1,868,645-99.4%$-48.1M
ReducedSTOKE THERAPEUTICS INC-725,269-15.2%$-23.7M
ReducedXENCOR INC-518,204-96.6%$-8.3M
ReducedIMMATICS N.V-193,737-89.3%$-2.0M
Sold outDESIGN THERAPEUTICS INC-119,516-100.0%$-1.3M
ReducedPRECISION BIOSCIENCES INC-34,647-3.5%$-272.3K
ReducedENTRADA THERAPEUTICS INC-33,083-15.6%$-243.5K
Sold outIBIO INC-68,076-100.0%$-129.3K
ReducedCG ONCOLOGY INC-200-0.6%$-14.2K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $114.6MQ1 2022: $107.7MQ2 2022: $117.4MQ3 2022: $110.9MQ4 2022: $115.6MQ1 2023: $119.9MQ2 2023: $152.6MQ3 2023: $151.2MQ4 2023: $254.3MQ1 2024: $388.2MQ2 2024: $277.2MQ3 2024: $282.2MQ4 2024: $266.7MQ1 2025: $279.2MQ2 2025: $346.2MQ3 2025: $491.3MQ4 2025: $494.0MQ1 2026: $632.7MQ2 2026: $865.5M
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1GH RESEARCH PLCORDINARY SHARES13,263,288$356.5M41.19%
2CULLINAN THERAPEUTICS INCCOM8,963,500$163.2M18.86%
3STOKE THERAPEUTICS INCCOM4,038,404$132.1M15.27%
4AGIOS PHARMACEUTICALS INCCOM3,408,937$126.5M14.62%
5C4 THERAPEUTICS INCCOM STK7,326,691$34.2M3.95%
6KORRO BIO INCCOM1,538,296$20.3M2.34%
7TSCAN THERAPEUTICS INCCOM8,019,148$7.9M0.91%
8PRECISION BIOSCIENCES INCCOM NEW950,466$7.5M0.86%
9NEUPHORIA THERAPEUTICS INCCOM875,328$3.8M0.44%
10PASSAGE BIO INCCOM NEW673,759$3.3M0.38%
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.